ArticleTheranostics2020

An ultralow dose of the NADPH oxidase inhibitor diphenyleneiodonium (DPI) is an economical and effective therapeutic agent for the treatment of colitis-associated colorectal cancer.

Yue Kuai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.